Summary. A pregnancy at risk for the Sanfilippo syndrome has been studied in which clear evidence was obtained from the study of amniotic fluid and fetal organs that the fetus was affected. Increased levels ofheparan sulphate were found in amniotic fluid and fetal liver, while electronmicroscopy of cultured fetal fibroblasts and fetal liver showed abnormal cytoplasmic inclusions. 35S04 uptake studies of cultured fetal cells showed abnormal intracellular accumulation of mucopoly saccharide, while both cultured amniotic cells and fetal skin fibroblasts demonstrated deficiency of heparin sulphamidase, the enzyme responsible for the 'A' subtype of the disease. It is suggested that by use of a combination of these methods Sanfilippo A disease can now be diagnosed reliably in utero.
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In the mucopolysaccharidoses cultured skin fibroblasts show excessive accumulation and prolonged turnover time of sulphated mucopolysaccharides which is due to the inactivity of enzymes involved in their degradation (Fratantoni, Hall, and Neufeld, 1968) . The Sanfilippo syndrome (mucopolysaccharidosis III) has been demonstrated to be biochemically heterogeneous (Kresse et al, 1971 ). The inactivity of either a heparin (heparan sulphate) sulphamidase (Sanfilippo A disease- Kresse and Neufeld, 1972; Kresse 1973) , or an N-acetyl-a-D-glucosaminidase (Sanfilippo B disease-O 'Brien, 1972; Figura and Kresse, 1972) , both enzymes necessary for normal heparan sulphate degradation, leads to the same clinical picture.
Increasing understanding of the metabolic basis of the mucopolysaccharidoses has led to the possibility of their prenatal detection, and successful prenatal diagnosis of the Hurler (mucopolysaccharidosis I) and Hunter (mucopolysaccharidosis II) diseases has been reported (Fratantoni et al, 1969; Crawfurd et al, 1973) .
We should like to report details of a family in which a fetus affected by Sanfilippo A disease was clearly identified by a number of different methods, suggesting that reliable prenatal diagnosis of this disorder by amniocentesis is feasible.
Family Details
The pregnancy studied was the second of a healthy unrelated couple from South Wales, the mother being of Maltese origin. Their first child (Fig. 1) , a male born in November 1966 was first investigated because of speech delay, behaviour disturbance, and mental retardation at age 5 years. Coarse facial features and hirsutism suggested the possibility of a mucopolysaccharidosis, but there was no hepatosplenomegaly or corneal clouding. Skeletal x-rays showed slight anterior beaking of the vertebrae but were not diagnostic of mucopolysaccharidosis. No inclusion bodies were seen on the blood film and the karyotype was normal. Initial screening tests for mucopolysaccharides were coilicting, but the diagnosis of Sanfilippo syndrome was established by the finding of large amounts of heparan sulphate in the urine (Table I) .
At the time of diagnosis of the first child the mother was again 24 weeks pregnant. Since a confident prenatal diagnosis based on study of amniotic fluid could not be offered, and since there was insufficient time for culture of amniotic cells, a termination of the pregnancy on the basis of a 1 in 4 risk was offered and was carried out at 25 weeks' gestation.
Materials and Methods
Samples of amniotic fluid and fetal tissues were obtained at the time of termination of the pregnancy by hysterotomy. Tissues for biochemical studies were immediately frozen at -20°C and kept at this temperature until analysis. Samples for electronmicroscopy were cut into 1-mm3 fragments and fixed immediately in 6% glutaraldehyde in phosphate buffer for 2 hours at pH 7A4, and post-fixed in 2% osmium tetroxide in veronal acetate buffer (pH 7.4 Ferguson-Smith et al, 1973; Whiteman, 1973) . The mucopolysaccharide content of fetal tissues was measured after they had been extracted by ethanol, acetone and diethylether, and drying in air. The solid tissues were then digested by deoxyribonuclease and ribonuclease followed by overnight digestion with papain at 650 C (Scott, 1960) . Mucopolysaccharides rendered soluble by this treatment and urinary mucopolysaccharides were fractionated on Dowex 1 x 2 (Cl-) resin and assayed for hexuronic acid (Bitter and Muir, 1962) , hexosamines (amino-acid Analyzer), and glucosamine residues with a free or Nsulphated amino group (Lagunoff and Warren, 1962 (Kresse et al, 1971) .
Skin fibroblasts grown to confluency in a 75-cm2 plastic flask (Greiner) were harvested by trypsinization, suspended in 0 5 ml. 0 075 N NaCl, and subjected to 10 Skin fibroblast extracts were incubated for 6 hours, amniotic fluid cell extracts for 16 hours, and organ extracts for 16-24 hours at 370 C. At the end of the incubation period the sulphate released was determined by paper electrophoresis in a barbital-acetate-N-cetyl pyridinium chloride buffer according to Kresse (1973) .
For the determination of N-acetyl-a-D-glucosaminidase activity 100 1A. cell homogenate were incubated for 6-15 hours at 370 C in the presence of 0-01 M o-nitrophenyl-a-D-N-acetylglucosaminide or 0-01 M phenyl-a-D-N-acetylglucosaminide. At the end of the incubation period N-acetylglucosamine liberated was determined by the Morgan-Elson reaction (Reissig, Strominger, and Leloir, 1959) . Other glycoside hydrolases were determined as described by Werries, Pott, and Buddecke (1972 The electrophoretic pattern is shown in Fig. 2 . Fig. 2a shows absence of the well-marked hyaluronic acid component normally present at this stage of gestation and the presence of increased amounts of material with mobility slightly less than that of the heparan sulphate standard. Due to the diversity of molecular species of heparan sulphate, the mobility of material in subjects with Sanfilippo syndrome has sometimes been found to be less than that of the standard heparan sulphate preparation. In Fig. 2b (Fig. 4) . A full report of electronmicroscopic findings is to follow (G. R. Newman, in preparation).
Cellular Incorporation of 35Sulphate. Figure  5 shows the uptake of 35S inorganic sulphate by cultured skin fibroblasts of the at risk fetus compared with those of a normal fetus of 17 weeks' gestation. Continued accumulation of isotope is seen at 4 days, in contrast to the levelling off in the control cells, suggesting failure of release of mucopolysaccharide from the lysosomal pool.
Determination of Heparin Sulphamidase and Glycoside Hydrolases. Figure 6 shows that fibroblasts cultured from the skin of the fetus at risk for the Sanfilippo syndrome do not release inorganic sulphate from heparin-N-35SO4 in significant amounts. Fibroblasts from a control fetus exhibit normal sulphamidase activity (Table IV) . For eight skin fibroblast lines of other than Sanfilippo A genotype the mean heparin sulphamidase activity was 9-41 ± 2-55 pmol/mg protein/min, whereas five Sanfilippo A cell lines had an activity of 0 30 ± 0 19 pmol/mg protein/min (Kresse, 1973) . Since essentially normal values for N-acetyl-a-Dglucosaminidase activity have been measured in skin fibroblasts of the fetus at risk, the results obtained establish the diagnosis of Sanfilippo A disease. This was confirmed by correction studies kindly carried out by Dr Elizabeth Neufeld on cultured fetal skin fibroblasts.
The deficiency of heparin sulphamidase activity was also found in cultured amniotic fluid cells. Shortage of material prevented the determination of N-acetyl-a-D-glucosaminidase activity in those cells. 
